KFDA to re-categorize drugs

Published: 2013-01-16 06:58:00

Updated: 2013-01-16 06:58:00

The Korea Food and Drug Administration (KFDA) will re-categorize 507 medicines from March as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.

The authorities will re-evaluate the effect of the deregulation in May and will add to or redu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK